Compare Keysight Technologies Inc (KEYS) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Keysight Technologies Inc vs Moderna, Inc. — how do they compare? Keysight Technologies Inc trades at $329.98 (market cap $53.68B), while Moderna, Inc. trades at $59.71 (market cap $23.60B). The key difference: Keysight Technologies Inc is far larger — about 2.3× Moderna, Inc.'s market cap, and Keysight Technologies Inc is trading nearer its 52-week high, Moderna, Inc. nearer its low. Which is the better fit depends on your goals.
| KEYS | MRNA | |
|---|---|---|
Market Cap | $53.68B | $23.60B |
Sector | Technology | Health |
52-Week High | $373.34 | $81.80 |
52-Week Low | $158.51 | $22.36 |
Enterprise Value | $54.03B | $19.70B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Keysight Technologies Inc
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
Read more on KEYS →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
